for the hormonal gel. The shorthand name is NES/T, as it’s a combination of nesterone to block the production of natural testosterone in the testes and bring down sperm count low enough to prevent pregnancy, and replacement testosterone to maintain sex drive. “It is a big relief for the women, [especially] for those that have tried one, two, three or four different types of contraception,” she told Jezebel. Dr.
The phase two trial of 420 couples started in the fall of 2018, and a phase three will follow, which will take three to four years. Then researchers have to seek FDA approval, so we won’t see contraceptive gel on the market for another five to 10 years from now, Dr. Wang said. Other options further behind the gel in development include a daily pill and an injection.Dr.
MCI is the second largest funder of male contraceptive research behind the National Institutes of Health, but at $1 million to $1.5 million a year, it’s comparable to “a rounding error” for overall drug development, Vahdat said. MCI isContraline, the company developing a reversible sperm-blocking injection in the US that’s known as ADAM, Vahdat said.
Men and people who produce sperm increasingly want to share the responsibility of preventing pregnancy, Vahdat said. “There’s a generational leap that’s taken place,” she told me. “I was talking to a couple in Delhi and the man said, ‘I just wish there was something I could take so that she didn’t have to deal with side effects.’” MCI also talks to young people who are “shocked” there isn’t male birth control yet.